{
  "meta": {
    "timestamp": "2025-01-06T14:18:23.265147",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "RxSight Inc.",
      "symbol": "RXST",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Market Competition: Intense competition from established players offering traditional IOLs and other vision correction technologies.",
            "Regulatory Risks: Stringent regulatory requirements and potential delays in obtaining approvals.",
            "Dependence on Key Products: Heavy reliance on the success of its Light Adjustable Lens (LAL) and Light Delivery Device (LDD).",
            "Pricing and Reimbursement: Premium pricing may limit adoption in cost-sensitive markets, and reimbursement challenges could affect patient access.",
            "Financial Performance: Significant operating losses and negative cash flows, with an accumulated deficit of $616.2 million as of September 30, 2024."
          ],
          "controversies": [
            "IPO and Public Offerings: Increased scrutiny on financial performance and governance following the 2021 IPO and subsequent public offerings."
          ],
          "environmental_issues": [],
          "social_issues": [
            "Patient Access: Potential limitations in patient access due to premium pricing and reimbursement challenges."
          ],
          "governance_issues": [
            "Corporate Governance: Increased scrutiny on governance practices following the IPO and public offerings."
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "California Declaration of Compliance | The Light Adjustable Lens from ...",
              "snippet": "Last Updated: November 12, 2024 RxSight, Inc. (RxSight) is a medical device manufacturer that is committed to conducting its business with integrity and in compliance with all applicable laws. RxSight has established a Comprehensive Compliance Program (CCP) that is reasonably designed with consideration given to the goals of California Health and Safety Code \u00a7\u00a7 119400 [\u2026]",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:17:58.673466+00:00",
              "published_date": null,
              "source_hash": "d98249e520416b6edac69437eda7bdc8"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "RxSight, Inc. Maureen O'Connell Senior Vice President, Clinical/Regulatory Affairs 100 Columbia Aliso Viejo, California 92656 Re: K231466 Trade/Device Name: \u00aeRxSight Insertion Device Regulation Number: 21 CFR 886.4300 Regulation Name: Intraocular Lens Guide Regulatory Class: Class I, reserved Product Code: MSS Dated: May 19, 2023",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T21:17:53.423059+00:00",
              "published_date": null,
              "source_hash": "36b3c2797071eca249614e08fe16ce6f"
            },
            {
              "url": "",
              "title": "RXSIGHT, INC. CODE OF BUSINESS CONDUCT AND ETHICS A. PURPOSE Code",
              "snippet": "RXSIGHT, INC. CODE OF BUSINESS CONDUCT AND ETHICS (Adopted on July 1, 2021 and effective as of the Company's initial public offering) A. PURPOSE . This Code of Business Conduct and Ethics (this \" Code \") is designed to deter wrongdoing and to promote: 1. fair and accurate financial reporting; 2.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T21:17:53.423074+00:00",
              "published_date": null,
              "source_hash": "96d4cdbe1be14ab9abbe0d4658742bde"
            },
            {
              "url": "",
              "title": "Premarket Approval (PMA) - Food and Drug Administration",
              "snippet": "RxSight Light Adjustable Lens and Light Delivery Device: Generic Name: Light adjustable lens (LAL) and light delivery device (LDD) Regulation Number: 886.3600: Applicant: RxSight, Inc. 100 Columbia Aliso Viejo, CA 92656: PMA Number: P160055: Supplement Number: S015: Date Received: 10/22/2020: Decision Date: 04/20/2021: Product Code: PZK ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T21:17:53.423084+00:00",
              "published_date": null,
              "source_hash": "a34e10862276dbbaffb5eea57dca2af0"
            },
            {
              "url": "",
              "title": "Premarket Approval (PMA) - Food and Drug Administration",
              "snippet": "Device: Light Adjustable Lens, Light Delivery Device: Generic Name: Light adjustable lens (LAL) and light delivery device (LDD) Regulation Number: 886.3600",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T21:17:53.423095+00:00",
              "published_date": null,
              "source_hash": "3defefdd8a5aec80633caf2b7b89fc06"
            },
            {
              "url": "",
              "title": "RxSight Investor Presentation",
              "snippet": "are based on the current beliefs of the RxSight, Inc. (\"RxSight,\" \"we\" or \"us\") management as well as assumptions made by and information currently available to RxSight. ... (viii) the ability to rec eive regulatory approvals and commercialize in selected international markets, (ix) the continued acceptance of our products in the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T21:17:53.423104+00:00",
              "published_date": null,
              "source_hash": "6aaa28905a335e9775360903e712c8c3"
            },
            {
              "url": "",
              "title": "RxSight, Inc. hiring Director, Regulatory Compliance in Aliso Viejo ...",
              "snippet": "Director Regulatory Compliance in Boydton, VA Expand search. ... RxSight, Inc. Aliso Viejo, CA 4 weeks ago Be among the first 25 applicants See who RxSight, Inc. has hired for this role ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T21:17:53.423113+00:00",
              "published_date": null,
              "source_hash": "ef726459153821d6080000595962aa03"
            },
            {
              "url": "",
              "title": "RxSight, Inc. - AnnualReports.com",
              "snippet": "RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight\u00ae Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens\u00ae (LAL\u00ae), RxSight Light Delivery Device (LDD\u2122) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted \u2026",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:17:58.673384+00:00",
              "published_date": null,
              "source_hash": "1b1e7d8da4e9e30b9d53bdba955666d9"
            },
            {
              "url": "",
              "title": "RxSight, Inc. Senior Regulatory Affairs Specialist Job in Aliso Viejo ...",
              "snippet": "RxSight, Inc. is now hiring a Full-time Senior Regulatory Affairs Specialist in Aliso Viejo, CA. View job listing details and apply now.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T21:17:53.423132+00:00",
              "published_date": null,
              "source_hash": "6859ab703d67ee0c5436523b9882c92b"
            },
            {
              "url": "",
              "title": "RxSight, Inc. Regulatory Affairs and Compliance Specialist I Salary ...",
              "snippet": "The average salary for Regulatory Affairs and Compliance Specialist I at companies like RxSight, Inc. in the United States is $69,803 as of August 27, 2024, but the salary range typically falls between $60,833 and $78,823.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T21:17:53.423140+00:00",
              "published_date": null,
              "source_hash": "3603f3508bdf8ad9d34f3f3626008f7e"
            },
            {
              "url": "",
              "title": "RxSight (RXST) Upgraded to Buy: Here's What You Should Know",
              "snippet": "Investors might want to bet on RxSight, Inc. (RXST), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:18:01.100257+00:00",
              "published_date": "2024-12-17T08:15:00+00:00",
              "source_hash": "fc4b259dc3d7c25e838154a1f7f5cd96"
            },
            {
              "url": "",
              "title": "RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference",
              "snippet": "ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T21:17:57.105654+00:00",
              "published_date": "2025-01-02T21:08:00+00:00",
              "source_hash": "70af2cc390fdea8699835b5a32d07be7"
            },
            {
              "url": "",
              "title": "Positive week for RxSight, Inc. (NASDAQ:RXST) institutional investors who lost 1.6% over the past year",
              "snippet": "To get a sense of who is truly in control of RxSight, Inc. (NASDAQ:RXST), it is important to understand the ownership structure of the business. We can see that institutions own the lion's share ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T21:17:57.105668+00:00",
              "published_date": "2024-12-20T06:32:00+00:00",
              "source_hash": "d6ef4a7a864e215a7047904e328be054"
            },
            {
              "url": "",
              "title": "Rxsight, Inc. To Present At The J.P. Morgan Healthcare Conference",
              "snippet": "(MENAFN- GlobeNewsWire - Nasdaq) ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T21:17:57.105679+00:00",
              "published_date": "2025-01-02T16:15:00+00:00",
              "source_hash": "0c411b60229402d29cd19c9bad9dbc72"
            },
            {
              "url": "",
              "title": "RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference",
              "snippet": "ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T21:17:57.105689+00:00",
              "published_date": "2025-01-03T05:06:00+00:00",
              "source_hash": "5e08dd82ab179570e15afcdfb28cad7d"
            },
            {
              "url": "",
              "title": "RxSight Investor Presentation",
              "snippet": "This presentation contains forward -looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements in this presentation that are not statements of historical fact ... Inc. (\"RxSight,\" \"we\" or \"us\") management as well as assumptions made by and information currently available to RxSight ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:17:58.673276+00:00",
              "published_date": null,
              "source_hash": "f180f3989280bb0710450b8c88808c60"
            },
            {
              "url": "",
              "title": "RxSight, Inc. (RXST): history, ownership, mission, how it works & makes ...",
              "snippet": "[relinking] Home History Owners Mission How It Works How It Makes Money RxSight, Inc. (RXST) Information A Brief History of RxSight, Inc. RxSight, Inc. began generating revenue from its principal operations in 2019. Since its inception, the company has faced significant operating losses and negative cash flows. As of September 30, 2024, RxSight reported an accumulated deficit of $616.2 million ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:17:58.673405+00:00",
              "published_date": null,
              "source_hash": "c156275f881752b0fbc74db9d167fe98"
            },
            {
              "url": "",
              "title": "RxSight, Inc. (RXST) Stock Price, News, Quote & History - Yahoo Finance",
              "snippet": "Find the latest RxSight, Inc. (RXST) stock quote, history, news and other vital information to help you with your stock trading and investing.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:17:58.673417+00:00",
              "published_date": null,
              "source_hash": "5ecb8be04eafe6e002a28224597c6cc5"
            },
            {
              "url": "",
              "title": "RxSight, Inc. Company Profile | Aliso Viejo, CA | Competitors ...",
              "snippet": "Find company research, competitor information, contact details & financial data for RxSight, Inc. of Aliso Viejo, CA. Get the latest business insights from Dun & Bradstreet.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:17:58.673427+00:00",
              "published_date": null,
              "source_hash": "ed82ff86ef2de0c29373964ceeef5c1a"
            },
            {
              "url": "",
              "title": "RxSight, Inc. (RXST) Stock Price, News, Quote & History - Yahoo Finance",
              "snippet": "The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:17:58.673437+00:00",
              "published_date": null,
              "source_hash": "5f0443352224ed1b2366a51901fd706b"
            },
            {
              "url": "",
              "title": "RXST | RxSight Inc. Profile - MarketWatch",
              "snippet": "RxSight Inc. RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:17:58.673447+00:00",
              "published_date": null,
              "source_hash": "9072ed301729aae076b239cc19c8be03"
            },
            {
              "url": "",
              "title": "Investor FAQs - RxSight",
              "snippet": "RxSight, Inc. was incorporated in California in 1997 as Calhoun Vision, and changed its name to RxSight, Inc. in October of 2016. RxSight was reincorporated in Delaware in July of 2021. On what stock exchange are RxSight shares traded and what is the ticker symbol?",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:17:58.673456+00:00",
              "published_date": null,
              "source_hash": "cab334ff01db793e6bce264526568534"
            },
            {
              "url": "",
              "title": "RxSight, Inc. Stock (RXST) - Quote Nasdaq- MarketScreener",
              "snippet": "RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company\u00e2 s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:17:58.673476+00:00",
              "published_date": null,
              "source_hash": "071565052c8469071b5f53173a618eef"
            },
            {
              "url": "",
              "title": "RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference",
              "snippet": "RxSight's management is scheduled to present on Wednesday, January 15, 2025, at 9:45 a.m. Pacific Time / 12:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:06.115189+00:00",
              "published_date": "2025-01-02T21:22:00+00:00",
              "source_hash": "99837d1c0c46d5cdb630e54ffcb3ce6f"
            },
            {
              "url": "",
              "title": "Positive week for RxSight, Inc. (NASDAQ:RXST) institutional investors who lost 1.6% over the past year",
              "snippet": "To get a sense of who is truly in control of RxSight, Inc. (NASDAQ:RXST), it is important ... It's therefore worth looking at RxSight's earnings history below. Of course, the future is what ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:18:01.100243+00:00",
              "published_date": "2024-12-20T06:32:00+00:00",
              "source_hash": "e401615140497381ea380450bb763c26"
            },
            {
              "url": "",
              "title": "Do You Believe in the Long-Term Growth Potential of RxSight (RXST)?",
              "snippet": "Brown Capital Management, an investment management company, released its \"The Brown Capital Management Small Company Fund\" third quarter 2024 investor letter. A copy of the letter can be downloaded here.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:18:01.100251+00:00",
              "published_date": "2024-12-20T14:43:56+00:00",
              "source_hash": "ae58beb17d490f4c0bafdff914ce5701"
            },
            {
              "url": "",
              "title": "RxSight, Inc. (RXST)",
              "snippet": "ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "RxSight Inc. RxSight Inc. litigation history",
              "retrieved_at": "2025-01-06T21:18:01.100262+00:00",
              "published_date": "2025-01-02T00:00:00+00:00",
              "source_hash": "f637f91bf05ecdaf9011f671ccc7ead2"
            },
            {
              "url": "",
              "title": "RxSight, Inc. Announces Pricing of Initial Public Offering - Yahoo Finance",
              "snippet": "ALISO VIEJO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the pricing of its initial public offering of 7,350,000 shares of common ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:02.558800+00:00",
              "published_date": null,
              "source_hash": "ab4cf5f75cbc9d21c8bcfb9003f17d35"
            },
            {
              "url": "",
              "title": "RxSight, Inc. Announces Pricing of Public Offering of Common Stock",
              "snippet": "RxSight expects to sell 1,785,714 shares of its common stock at a price to the public of $56.00 per share. RxSight has granted the underwriters a 30-day option to purchase up to an additional ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:02.558845+00:00",
              "published_date": null,
              "source_hash": "ec162c40cb9ba4efd178451176f51c77"
            },
            {
              "url": "",
              "title": "RxSight, Inc. Announces Pricing of Public Offering of - GlobeNewswire",
              "snippet": "About RxSight, Inc. RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:02.558858+00:00",
              "published_date": null,
              "source_hash": "539b1d500b713b67a4ad867667dd6e9c"
            },
            {
              "url": "",
              "title": "RxSight, Inc. Announces Pricing of Public Offering of Common Stock",
              "snippet": "RxSight expects to sell 4,000,000 shares of its common stock at a price to the public of $12.50 per share. RxSight has granted the underwriter a 30-day option to purchase up to an additional ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:02.558869+00:00",
              "published_date": null,
              "source_hash": "6ddceb1664369a3b99dd4e0fe8ead392"
            },
            {
              "url": "",
              "title": "Analyst Scoreboard: 7 Ratings For RxSight - Nasdaq",
              "snippet": "In the assessment of 12-month price targets, analysts unveil insights for RxSight, presenting an average target of $63.14, a high estimate of $72.00, and a low estimate of $54.00.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:02.558878+00:00",
              "published_date": null,
              "source_hash": "f9bf6226e8069a5c8410f314422386f4"
            },
            {
              "url": "",
              "title": "RxSight Announces Pricing of Public Offering of Common Stock",
              "snippet": "RxSight expects to sell 4,000,000 shares of its common stock at a price to the public of $12.50 per share. RxSight has granted the underwriter a 30-day option to purchase up to an additional 600,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. All of the shares are to be sold by RxSight.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:02.558887+00:00",
              "published_date": null,
              "source_hash": "15a73195ab9a216e7870abdc6ec7b168"
            },
            {
              "url": "",
              "title": "RxSight, Inc. Announces Closing of Initial Public Offering and Partial ...",
              "snippet": "ALISO VIEJO, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the closing of its initial public offering of 7,350,000 shares of common stock on August 3, 2021, as well as the partial exercise of the underwriters' option to purchase an additional 898,594 additional shares of common stock, which closed on August 4, 2021, in each ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:02.558897+00:00",
              "published_date": null,
              "source_hash": "8017cbb5977572f71f68b22642db4657"
            },
            {
              "url": "",
              "title": "RxSight | RXST Stock Price, Company Overview & News - Forbes",
              "snippet": "RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:02.558907+00:00",
              "published_date": null,
              "source_hash": "3aa1e71dd329fc5c81ef8e81c919789a"
            },
            {
              "url": "",
              "title": "RxSight Inc RXST Overview - U.S. News",
              "snippet": "RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:02.558916+00:00",
              "published_date": null,
              "source_hash": "68f3862a041901bb15c92954c37b125d"
            },
            {
              "url": "",
              "title": "RXST Stock Quote, News, and History - Markets Insider",
              "snippet": "On Wednesday 12/25/2024 the closing price of the RxSight Inc Registered Shs share was $34.46 on BTT. Compared to the opening price on Wednesday 12/25/2024 on BTT of $34.58, this is a drop of 0.35%",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:02.558924+00:00",
              "published_date": null,
              "source_hash": "76f60413f1480f11191e9a5d492622c3"
            },
            {
              "url": "",
              "title": "RxSight, Inc. (NASDAQ:RXST) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?",
              "snippet": "Last week, you might have seen that RxSight, Inc. (NASDAQ:RXST) released its third-quarter result to the market. The early response was not positive, with shares down 6.0% to US$48.01 in the past ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:06.115215+00:00",
              "published_date": "2024-11-09T00:00:00+00:00",
              "source_hash": "9140c9784ef47a833767ac727d6773c7"
            },
            {
              "url": "",
              "title": "Forecasting The Future: 4 Analyst Projections For RxSight",
              "snippet": "Analysts have set 12-month price targets for RxSight, revealing an average target of $51.5, a high estimate of $72.00, and a low estimate of $40.00. This current average represents a 14.88% decrease from the previous average price target of $60.50.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:06.115221+00:00",
              "published_date": "2024-12-20T12:01:00+00:00",
              "source_hash": "ceb89783efa709c7f6b1fc33be0c3049"
            },
            {
              "url": "",
              "title": "RxSight, Inc. (RXST)",
              "snippet": "Sustainalytics' Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company's operations. Controversies ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "RxSight Inc. RxSight Inc. pricing and reimbursement controversies",
              "retrieved_at": "2025-01-06T21:18:06.115225+00:00",
              "published_date": "2024-12-27T23:42:00+00:00",
              "source_hash": "02e3f325a10055c88abfd47154dc1e76"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "RxSight Inc. regulatory compliance issues",
              "rationale": "Investigate potential delays or issues with FDA and international regulatory approvals",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "RxSight Inc. litigation history",
              "rationale": "Identify any past or ongoing legal disputes that could impact the company",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "RxSight Inc. pricing and reimbursement controversies",
              "rationale": "Explore concerns related to the premium pricing of its products and reimbursement challenges",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T14:18:23.265151",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}